REVBW
Revelation Biosciences IncNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-4.77
Beta
-0.14
52W High
$0.02
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Revelation Biosciences Inc
Revelation Biosciences Inc is a leading biotechnology firm focused on pioneering therapeutic solutions for respiratory diseases, including allergies and asthma. Utilizing its proprietary research platform, the company aims to address substantial unmet medical needs through innovative R&D initiatives. Committed to improving patient outcomes, Revelation collaborates with key industry stakeholders while navigating the complexities of regulatory compliance in the biopharmaceutical sector. With a robust pipeline of potential therapies, Revelation is strategically poised to make a significant impact on the lives of patients grappling with respiratory conditions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-9.04M |
| Operating Margin | 0.00% |
| Return on Equity | -131.40% |
| Return on Assets | -62.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.59 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $3.27M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
12.72%
HV 20-Day
68.29%
HV 30-Day
55.28%
HV 60-Day
67.91%
HV Rank
—
Volatility is currently contracting
Data last updated: 5/5/2026